The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Antibody-Based Protein Multiplex Platforms: Technical and Operational Challenges
Open accessAbstract
Background: The measurement of multiple protein biomarkers may refine risk stratification in clinical settings. This concept has stimulated development of multiplexed immunoassay platforms that provide multiple, parallel protein measurements on the same specimen. Content: We provide an overview of antibody-based multiplexed immunoassay platforms and discuss technical and operational challenges. Multiplexed immunoassays use traditional immunoassay principles in which high-affinity capture ligands are immobilized in parallel arrays in either planar format or on microspheres in suspension. Development of multiplexed immunoassays requires rigorous validation of assay configuration and analytical performance to minimize assay imprecision and inaccuracy. Challenges associated with multiplex configuration include selection and immobilization of capture ligands, calibration, interference between antibodies and proteins and assay diluents, and compatibility of assay limits of quantification. We discuss potential solutions to these challenges. Criteria for assessing analytical multiplex assay performance include the range of linearity, analytical specificity, recovery, and comparison to a quality reference method. Quality control materials are not well developed for multiplexed protein immunoassays, and algorithms for interpreting multiplex quality control data are needed. Summary: Technical and operational challenges have hindered implementation of multiplexed assays in clinical settings. Formal procedures that guide multiplex assay configuration, analytical validation, and quality control are needed before broad application of multiplexed arrays can occur in the in vitro diagnostic market.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Protein microarrays and proteomics
MacBeath, G. (2002) · Nature Genetics · doi:10.1038/ng1037 · Cited by 846
A multi-rule Shewhart chart for quality control in clinical chemistry.
Westgard, J. O., Barry, P. L., Hunt, M. R., & Groth, T. (1981) · Clinical Chemistry · doi:10.1093/clinchem/27.3.493 · Cited by 831
Multiplexed protein measurement: technologies and applications of protein and antibody arrays
Kingsmore, S. F. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2006 · Cited by 715
(2009) · Humana Press eBooks · doi:10.1007/978-1-59745-240-3 · Cited by 582
Cytometric bead array: a multiplexed assay platform with applications in various areas of biology
Morgan, E., Varro, R., Sepulveda, H., Ember, J. A., Apgar, J., Wilson, J., Lowe, L., Chen, R., Shivraj, L., Agadir, A., et al. (2004) · Clinical Immunology · doi:10.1016/j.clim.2003.11.017 · Cited by 506
The five-parameter logistic: A characterization and comparison with the four-parameter logistic
Gottschalk, P. G., & Dunn, J. R. (2005) · Analytical Biochemistry · doi:10.1016/j.ab.2005.04.035 · Cited by 449
Cooper, M. A., & Singleton, V. T. (2007) · Journal of Molecular Recognition · doi:10.1002/jmr.826 · Cited by 370
Ekins, R. P. (1989) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/0731-7085(89)80079-2 · Cited by 294
Protein microarrays: Promising tools for proteomic research
Templin, M. F., Stoll, D., Schwenk, J. M., Pötz, O., Kramer, S., & Joos, T. O. (2003) · PROTEOMICS · doi:10.1002/pmic.200300600 · Cited by 244
Surface Plasmon Resonance Biosensing
Piliarik, M., Vaisocherová, H., & Homola, J. (2009) · Methods in Molecular Biology · doi:10.1007/978-1-60327-567-5_5 · Cited by 238
Next generation of protein microarray support materials:
Angenendt, P., Glökler, J., Sobek, J., Lehrach, H., & Cahill, D. J. (2003) · Journal of Chromatography A · doi:10.1016/s0021-9673(03)00769-6 · Cited by 214
Protein microarrays for diagnostic assays
Hartmann, M., Roeraade, J., Stoll, D., Templin, M. F., & Joos, T. O. (2009) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-008-2379-z · Cited by 173
Protein and antibody microarray technology
Glökler, J., & Angenendt, P. (2003) · Journal of Chromatography B · doi:10.1016/j.jchromb.2003.08.034 · Cited by 168
Solid-phase and bead-based cytokine immunoassay: A comparison
de Jager, W., & Rijkers, G. T. (2006) · Methods · doi:10.1016/j.ymeth.2005.11.008 · Cited by 160
Quintana, F. J., Hagedorn, P. H., Elizur, G., Merbl, Y., Domany, E., & Cohen, I. R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404848101 · Cited by 158
Haab, B. B., Geierstanger, B. H., Michailidis, G. C., Vitzthum, F., Forrester, S., Okon, R., Saviranta, P., Brinker, A., Sorette, M. P., Perlee, L. T., et al. (2005) · PROTEOMICS · doi:10.1002/pmic.200401276 · Cited by 151
Multiplexing molecular diagnostics and immunoassays using emerging microarray technologies
Ling, M. M., Ricks, C., & Lea, P. (2006) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.7.1.87 · Cited by 114
Tworoger, S. S., & Hankinson, S. E. (2006) · Cancer Causes & Control · doi:10.1007/s10552-006-0035-5 · Cited by 102
Protein microarrays for antibody profiling: Specificity and affinity determination on a chip
Poetz, O., Ostendorp, R., Brocks, B., Schwenk, J. M., Stoll, D., Joos, T. O., & Templin, M. F. (2005) · PROTEOMICS · doi:10.1002/pmic.200401299 · Cited by 92
Schwenk, J. M., Lindberg, J., Sundberg, M., et al. (2006) · Molecular & Cellular Proteomics · doi:10.1074/mcp.t600035-mcp200 · Cited by 86
de Vegvar, H. E. N., Amara, R. R., Steinman, L., Utz, P. J., Robinson, H. L., & Robinson, W. H. (2003) · Journal of Virology · doi:10.1128/jvi.77.20.11125-11138.2003 · Cited by 82
Measurement and Quality Control Issues in Multiplex Protein Assays: A Case Study
Ellington, A. A., Kullo, I. J., Bailey, K. R., & Klee, G. G. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.120717 · Cited by 75
Self-citationToedter, G. P., Hayden, K. E., Wagner, C. L., & Brodmerkel, C. M. (2007) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00211-07 · Cited by 70
Protein Microarrays and Multiplexed Sandwich Immunoassays: What Beats the Beads?
Templin, M. F., Stoll, D., Bachmann, J., & Joos, T. O. (2004) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207043328814 · Cited by 68
Cancer Biomarker Validation: Standards and Process
Barker, P. E. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb05969.x · Cited by 59
Human protein atlas and the use of microarray technologies
Hober, S., & Uhlén, M. (2008) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2007.11.006 · Cited by 59
Affinity reagent resources for human proteome detection: Initiatives and perspectives
Stoevesandt, O., & Taussig, M. (2007) · PROTEOMICS · doi:10.1002/pmic.200700155 · Cited by 57
Nichkova, M. I., Dosev, D., Gee, S. J., Hammock, B. D., & Kennedy, I. M. (2007) · Analytical Biochemistry · doi:10.1016/j.ab.2007.06.035 · Cited by 52
Protein and lysate array technologies in cancer research
Spurrier, B., Honkanen, P., Holway, A. H., Kumamoto, K., Terashima, M., Takenoshita, S., Wakabayashi, G., Austin, J., & Nishizuka, S. (2008) · Biotechnology Advances · doi:10.1016/j.biotechadv.2008.04.002 · Cited by 50
Recognition of biomarkers and cell‐specific molecular signatures: Aptamers as capture agents
Nery, A. A., Wrenger, C., & Ulrich, H. (2009) · Journal of Separation Science · doi:10.1002/jssc.200800695 · Cited by 47
Diagnostic challenges for multiplexed protein microarrays
Master, S. R., Bierl, C., & Kricka, L. J. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.09.010 · Cited by 45
Suspension microarrays for the identification of the response patterns in hyperinflammatory diseases
Hsu, H., SilkeWittemann, Schneider, E. M., Weiß, M., & Joos, T. O. (2008) · Medical Engineering & Physics · doi:10.1016/j.medengphy.2008.01.003 · Cited by 40
Protein microarray platform for the multiplex analysis of biomarkers in human sera
Urbanowska, T., Mangialaio, S., Zickler, C., Cheevapruk, S., Hasler, P., Regenass, S., & Legay, F. (2006) · Journal of Immunological Methods · doi:10.1016/j.jim.2006.03.019 · Cited by 33
High-throughput antibody microarrays for quantitative proteomic analysis
Lv, L., & Liu, B. (2007) · Expert Review of Proteomics · doi:10.1586/14789450.4.4.505 · Cited by 31
Computer-Assisted Pattern Recognition of Autoantibody Results
Binder, S. R., Genovese, M. C., Merrill, J. T., Morris, R. I., & METZGER, A. L. (2005) · Clinical and Vaccine Immunology · doi:10.1128/cdli.12.12.1353-1357.2005 · Cited by 28
Quality Control and Protein Microarrays
Kricka, L. J., & Master, S. R. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2009.126557 · Cited by 20
Montagnana, M., Volpe, A., Lippi, G., Caramaschi, P., Salvagno, G. L., Biasi, D., Bambara, L. M., & Guidi, G. C. (2007) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2007.03.023 · Cited by 18
Cited by
Lin, J.-R., Izar, B., Wang, S., Yapp, C., Mei, S., Shah, P. M., Santagata, S., & Sorger, P. K. (2018) · eLife · doi:10.7554/elife.31657 · Cited by 692
Uhlén, M., Karlsson, M. J., Hober, A., Svensson, A.-S., Scheffel, J., Kotol, D., Zhong, W., Tebani, A., Strandberg, L., Edfors, F., et al. (2019) · Science Signaling · doi:10.1126/scisignal.aaz0274 · Cited by 495
Quantitative analysis of peptides and proteins in biomedicine by targeted mass spectrometry
Gillette, M. A., & Carr, S. A. (2013) · Nature Methods · doi:10.1038/nmeth.2309 · Cited by 495
ELISA in the multiplex era: Potentials and pitfalls
Tighe, P. J., Ryder, R. R., Todd, I., & Fairclough, L. C. (2015) · PROTEOMICS – Clinical Applications · doi:10.1002/prca.201400130 · Cited by 464
Kartikasari, A. E. R., Huertas, C. S., Mitchell, A., & Plebanski, M. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.692142 · Cited by 343
Metadata
- Authors
- Ellington, A. A., Kullo, I. J., Bailey, K. R., & Klee, G. G.
- Venue
- Clinical Chemistry
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-02-01
- Volume
- 56
- Issue
- 2
- Pages
- 186-193
- ISSN
- 0009-9147 (ISSN-L)
- 1530-8561
- OpenAlex
- W2116490593
- Cited by
- 313
- References
- 37
- FWCI
- 7.08
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.